Literature DB >> 22325177

Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis.

Markus Brückner1, Sabine Westphal, Wolfram Domschke, Torsten Kucharzik, Andreas Lügering.   

Abstract

BACKGROUND AND AIMS: Leukocyte infiltration, up-regulation of proinflammatory cytokines and severe oxidative stress caused by increased amounts of reactive oxygen species are characteristics of inflammatory bowel disease. The catechin (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate), named epigallocatechin-3-gallate, EGCG, has been demonstrated to exert anti-inflammatory and antioxidative properties, reducing reactive oxygen species in the inflamed tissues. The aim of this study was to evaluate the therapeutic effects of EGCG in a murine model of colitis induced by oral administration of dextran sodium sulfate.
METHODS: Mice received a daily oral administration of 6.9 mg/kg body weight EGCG or Piper nigrum (L.) alkaloid (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one, named piperine (2.9 mg/kg body weight) or the combination of the both - piperine was used in this combination to enhance the bioavailability of EGCG.
RESULTS: In vivo data revealed the combination of EGCG and piperine to significantly reduce the loss of body weight, improve the clinical course and increase overall survival in comparison to untreated groups. The attenuated colitis was associated with less histological damages to the colon and reduction of tissue concentrations of malondialdehyde, the final product of lipid peroxidation. Neutrophils accumulation indicator myeloperoxidase was found to be reduced in colon tissue, while antioxidant enzymes like superoxide dismutase and glutathione peroxidase showed an increased activity. In vitro, the treatment with EGCG plus piperine enhanced the expression of SOD as well as GPO and also reduced the production of proinflammatory cytokines.
CONCLUSION: These data support the concept of anti-inflammatory properties of EGCG being generally beneficial in the DSS-model of colitis, an effect that may be mediated by its strong antioxidative potential.
Copyright © 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22325177     DOI: 10.1016/j.crohns.2011.08.012

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  30 in total

1.  Effect of epigallocatechin gallate on ischemia-reperfusion injury: an experimental study in a rat epigastric island flap.

Authors:  Cem Aslan; Cenk Melikoglu; Irfan Ocal; Gulcan Saglam; Recep Sutcu; Mubin Hosnuter
Journal:  Int J Clin Exp Med       Date:  2014-01-15

2.  Epigallocatechin-3-Gallate Inhibition of Myeloperoxidase and Its Counter-Regulation by Dietary Iron and Lipocalin 2 in Murine Model of Gut Inflammation.

Authors:  Beng San Yeoh; Rodrigo Aguilera Olvera; Vishal Singh; Xia Xiao; Mary J Kennett; Bina Joe; Joshua D Lambert; Matam Vijay-Kumar
Journal:  Am J Pathol       Date:  2016-03-08       Impact factor: 4.307

Review 3.  Plant natural products: from traditional compounds to new emerging drugs in cancer therapy.

Authors:  L Ouyang; Y Luo; M Tian; S-Y Zhang; R Lu; J-H Wang; R Kasimu; X Li
Journal:  Cell Prolif       Date:  2014-12       Impact factor: 6.831

Review 4.  Diet in the pathogenesis and treatment of inflammatory bowel diseases.

Authors:  Dale Lee; Lindsey Albenberg; Charlene Compher; Robert Baldassano; David Piccoli; James D Lewis; Gary D Wu
Journal:  Gastroenterology       Date:  2015-01-15       Impact factor: 22.682

Review 5.  Natural compounds as safe therapeutic options for ulcerative colitis.

Authors:  Mukta Gupta; Vijay Mishra; Monica Gulati; Bhupinder Kapoor; Amrinder Kaur; Reena Gupta; Murtaza M Tambuwala
Journal:  Inflammopharmacology       Date:  2022-02-25       Impact factor: 4.473

6.  Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T/T helper 17 cell balance in the treatment of colitis in mice.

Authors:  Zhenglei Xu; Cheng Wei; R U Zhang; Jun Yao; Dinguo Zhang; Lisheng Wang
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

7.  Beneficial role of Pistacia lentiscus aqueous extract in experimental colitis: anti-inflammatory and potential therapeutic effects.

Authors:  Insaf-Meriem Boutemine; Manel Amri; Karim Dorgham; Zine-Charaf Amir; Sara Benazzouz; Fahima Ameur; Karim Layaida; Hans Yssel; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2021-06-11       Impact factor: 4.473

Review 8.  Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.

Authors:  Sun Young Moon; Kwang Dong Kim; Jiyun Yoo; Jeong-Hyung Lee; Cheol Hwangbo
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

9.  EGCG promotes PRKCA expression to alleviate LPS-induced acute lung injury and inflammatory response.

Authors:  Mian Wang; Hua Zhong; Xian Zhang; Xin Huang; Jing Wang; Zihao Li; Mengshi Chen; Zhenghui Xiao
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

Review 10.  Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.

Authors:  Khushwant S Bhullar; H P Vasantha Rupasinghe
Journal:  Oxid Med Cell Longev       Date:  2013-06-06       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.